NVDA · NASDAQ-GS
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $215.94B | $130.50B | $60.92B | $26.97B | $26.91B | $16.68B | $10.92B | $11.72B |
| Cost of Revenue | $62.48B | $32.64B | $16.62B | $11.62B | $9.44B | $6.28B | $4.15B | $4.54B |
| Gross Profit | $153.46B | $97.86B | $44.30B | $15.36B | $17.48B | $10.40B | $6.77B | $7.17B |
| Research & Development | $18.50B | $12.91B | $8.68B | $7.34B | $5.27B | $3.92B | $2.83B | $2.38B |
| Selling, General & Administrative | $4.58B | $3.49B | $2.65B | $2.44B | $2.17B | $1.94B | $1.09B | $991.00M |
| Operating Expenses | $23.08B | $16.41B | $11.33B | $11.13B | $7.43B | $5.86B | $3.92B | $3.37B |
| Operating Income | $130.39B | $81.45B | $32.97B | $4.22B | $10.04B | $4.53B | $2.85B | $3.80B |
| Interest Expense | — | — | $257.00M | $262.00M | $236.00M | $184.00M | $52.00M | $58.00M |
| Other Income / (Expense) | $11.06B | $2.57B | $846.00M | -$43.00M | -$100.00M | -$123.00M | $124.00M | $92.00M |
| Income Before Taxes | $141.45B | $84.03B | $33.82B | $4.18B | $9.94B | $4.41B | $2.97B | $3.90B |
| Provision for Income Taxes | $21.38B | $11.15B | $4.06B | -$187.00M | $189.00M | $77.00M | $174.00M | -$245.00M |
| Net Income | $120.07B | $72.88B | $29.76B | $4.37B | $9.75B | $4.33B | $2.80B | $4.14B |
| Basic EPS | $4.93 | $2.97 | $1.21 | $0.18 | $3.91 | $1.76 | $1.15 | $6.81 |
| Diluted EPS | $4.90 | $2.94 | $1.19 | $0.17 | $3.85 | $1.73 | $1.13 | $6.63 |
| Basic Shares Outstanding | 24.36B | 24.55B | 24.69B | 24.87B | 2.50B | 2.47B | 2.44B | 608.00M |
| Diluted Shares Outstanding | 24.51B | 24.80B | 24.94B | 25.07B | 2.54B | 2.51B | 2.47B | 625.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $8.79 | $7.90 | $11.99 | 17 | ↑4 ↓0 |
| Jan 2028 | $12.13 | $9.27 | $14.23 | 13 | ↑3 ↓0 |
| Jan 2029 | $16.10 | $14.96 | $17.24 | 2 | ↑0 ↓0 |